Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

Jan 27 : Moody’s Downgrades Credit Rating for Partners HealthCare

partners healthcare

In a credit report released this month, Moody’s announced it’s downgrading the credit rating for Partners HealthCare from Aa2 to Aa3. Standard & Poor’s also revised its outlook from stable to negative on Partner’s AA-rated debt, meaning that it may be downgraded if the financial picture doesn’t improve.

For an entity that frequently issues and finances debt to fund its operations, a lower credit rating means higher interest rates, making such activity more expensive.

The agencies mainly cited Partner’s Managed Medicaid insurer Neighborhood Health Plan as the reason for the lowered outlook. That plan, which offers health insurance to many low-income residents, suffered a $202 million operating loss in fiscal 2014, including a $92 million estimated payment for anticipated losses. That contributed to a $22 million operating loss for Partners HealthCare as a whole in the same fiscal year.

The agencies also pointed to the pending departure of CEO Gary Gottlieb, who is expected to leave in July.

“We are uncertain if this will usher in a period of change going forward,” the S&P report said. “Partners’ board remains committed to its existing strategies through the transition process.”

Moody’s also said Partners’ plan to acquire South Shore Hospital, Hallmark Health System and Emerson Hospital, which has gotten considerable public backlash and is under judicial review in Suffolk Superior Court, could cause future financial problems.

“Partners operates under heightened public and political scrutiny that may limit the system’s strategic and financial flexibility to acquire other hospitals, physician groups, or pursue strategic alternatives with NHP,” Moody’s said in its report.

Rich Copp, a spokesman for Partners HealthCare, said that despite the challenges outlined in the reports, the two credit rating agencies and Fitch Ratings, which kept Partners at an AA rating, noted the organization’s effective leadership team.

While the ratings haven’t changed Partners’ strategy, it emphasizes ongoing work the organization is doing to change, Copp said.

“Our focus remains on cost controls that will help generate stable operating margins and enable us to deliver the type of world class care patients and families have come to expect, and we’ll continue to work with the state on squaring away the rate situation at NHP,” Copp said.

Source